- Report
- May 2025
- 185 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 183 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 190 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 198 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 184 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 190 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 194 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 194 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 193 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 193 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 187 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- May 2025
- 183 Pages
Global
From €3191EUR$3,545USD£2,733GBP
€3546EUR$3,939USD£3,037GBP
- Report
- June 2025
- 184 Pages
Global
From €5266EUR$5,850USD£4,511GBP
- Report
- April 2020
- 82 Pages
Global
From €2475EUR$2,750USD£2,120GBP

The Health Technology Assessment (HTA) market within the context of Pharmaceuticals is a rapidly growing industry. It is a process of evaluating the clinical, economic, and social impact of a medical technology, such as a drug, device, or procedure. HTA is used to inform decision-making in healthcare, such as reimbursement decisions, and to ensure that healthcare resources are used in the most effective and efficient way. HTA is conducted by independent organizations, such as government agencies, research institutes, and private companies.
HTA is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that new drugs are safe and effective, and that they provide value for money. HTA also helps to ensure that new drugs are used appropriately, and that they are targeted to the right patients.
Some companies in the HTA market include IQVIA, Parexel, Syneos Health, and Evidera. Show Less Read more